Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» INNO-206
INNO-206
CytRx falls 12% in morning trading
Marketwatch
Mon, 06/4/12 - 11:50 am
CytRx
INNO-206
soft tissue sarcomas
CytRx Announces Favorable Results from Phase 1b/2 Clinical Trial with INNO-206
Yahoo/Business Wire
Sun, 06/3/12 - 12:42 pm
CytRx
INNO-206
cancer
What Can We Expect From CytRx In 2012?
Seeking Alpha
Tue, 12/20/11 - 10:54 am
CytRx
Bafetinib
INNO-206
FDA grants "orphan drug" status to CytRx's experimental cancer drug
Yahoo/AP
Tue, 07/5/11 - 04:44 pm
orphan drugs
FDA
CytRx
INNO-206
cancer
CytRx Drug Candidate INNO-206 Results in Ovarian Tumor Shrinkage in Animal Trials
Yahoo
Tue, 07/28/09 - 08:57 am
CytRx
INNO-206
ovarian cancer
drug trials